Opened 284 days ago

Closes 31 December 2023

Trial Aim Description

Testing a potential new treatment/investigational product for (Inclusion Body Myositis) IBM. The potential new treatment/investigational product is called Sirolimus.

Trial Eligibility Requirements

Patients must have a confirmed diagnosis of IBM and be aged 45 years or older.

Interested? Enquire today

Principal Investigator: Professor Merrilee Needham

View more trials